Needham & Company initiated coverage with a buy rating, and Citigroup also provided a buy rating and price target.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company initiated coverage with a buy rating, and Citigroup also provided a buy rating and price target.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
-
Cerebras
business
- A composite article detailing several distinct corporate news items from July 1, 2026, including a CrowdStrike/Cerebras deal, an AMD/Cerbras partnership, Intel earnings, and Kinder Morgan profits.
- The article notes that both AMD and Cerebras are operating in the high-demand AI compute market, and Andrew Feldman is the CEO of Cerebras.
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup reissued a market outperform rating and Needham lifted its target price for Alkami Technology Inc.
- Needham & Company issued a buy rating, and Leerink Partners began coverage of Collegium Pharmaceutical, Inc. on September 23, 2026.
- Citigroup and Truist Financial issued buy ratings and increased price targets for Cisco.
- Citigroup raised shares to a buy rating for Fisher & Paykel Healthcare.
- Citigroup lifted its target price and gave a buy rating for BLOCK, while K&B&W upped its price objective and gave an outperform rating.